FDA Reducing Price of New Drugs Through Drug Competition Action Plan
The Theory At the American Society of Clinical Oncology (ASCO), FDA Commissioner Dr. Scott Gottlieb introduced the Drug Competition Action Plan, which aims to lower new drug pricing by increasing generic (alternative) drug competition in the pharmaceutical market....
China’s New Human Genetic Resources Policy
CHINA’S NEW HUMAN GENETIC RESOURCES POLICY New Regulation Underway On May 28, 2019, the Chinese government published new regulations on the management of Human Genetic Resources (HGRs). The main objective of the government is to observe all HGR- related activities,...
Observing Breast Cancer Awareness Month
Observing Breast Cancer Awareness MonthWhat is Breast Cancer? Breast cancer is a disease where breast cells grow uncontrollably and can spread through the blood and lymph vessels. Cancer develops when the human's genetic growth is messed up. Usually, cell growth...
Reducing the Side Effects of Chemo for Cancer Patients
A new cancer treatment device has been made which reduces the negative effects of chemotherapy on cancer patients.
Life Science Translation in The Digital Age: Fast Changes in a Slow Environment
Life science translation must be done quick and highly accurate to give life science companies the best ROI. Traditionally speaking, however, everything about the life science sector is slow moving. From research and development to regulatory changes and clinical...
DIA Global Conference 2018 – Boston June 24th-28th
It's that time of year again! In just a few short weeks the city of Boston will play host as thousands of people attend the DIA Global Conference. The 2018 annual meeting of the Drug Information Association will be held from June 24th to 28th this year and bring...
CSOFT Health Sciences Provides Live Interpretation Services at the 10th DIA China Conference
From May 23-25, CSOFT’s CSOFT Health Sciences' Life Sciences Unit attended and exhibited at the 10th DIA China Conference held at the Beijing International Convention Center. This year’s event attracted thousands of pharmaceutical R&D professionals from around the...
Life Science Translation and Global Language Trends – Infographic
As with translations for any other industry, life science translation needs are significantly impacted by global linguistic trends. Earlier this week I stumbled upon an interesting article on Visual Capitalist (Visualcapitalist.com) about the world's languages. Did...
How AI is Changing the Face of Translation
As the demand for quality affordable translations is ever increasing, companies are increasingly harnessing artificial intelligence (AI), moving beyond traditional translation memory and terminology management systems. When using artificial intelligence (AI) for...
Big Changes & Growth Coming in 2018 for CSOFT & CSOFT Health Sciences
Last week I had the privilege of traveling to CSOFT offices in San Francisco to meet with colleagues for a variety of meetings, team building exercises, and industry events. It is always an exciting time to meet with colleagues from around the world to celebrate our...
After Brexit – What It Means for Life Sciences
Continuing our conversation on the European Union, this week I'd like to take a look at the UK's withdrawal from the European Union, "Brexit", and the implications for life sciences. Due to the entwined nature of regulatory bodies for the EU, how will governments and...
European Union Translation Requirements
European Union translation requirements can seem overwhelming, as there are currently 24 official languages recognized in the EU. The EU's policy on multilingualism aims to preserve the broad linguistic diversity of Europe as well as foster an environment where...
The CDFA & the Chinese Pharmaceutical Industry
China is currently recognized as the world's second-largest pharmaceutical industry. However, the regulatory policies have been very challenging for many large foreign pharmaceutical enterprises, as well as innovative local companies. Some of the reasons for those...
CSOFT Launches Dedicated Life Science Business Unit for Medical Translations
I want to take this opportunity to share some exciting changes for CSOFT's medical translation services. At the beginning of this week, CSOFT International launched CSOFT Health Sciences.com. The dedicated Life Science Business Unit got a new home to better serve...
A New Year: Looking at 2018 Translation Conferences
The translation and localization industry is filled with translation conferences, learning events, and expos where leaders in the industry can…
Idioms: Don’t Cut Corners with Marketing Translations
One of the most difficult tasks that translators face is dealing with culturally specific content, such as idioms. Each language, in regular informal speech
Post-Editing: The Future of Linguistics?
Machine translation (MT), I know what you are thinking when you hear that phrase. Machine translations translate words, not language. While that may be…
Translation Quality is Required for China’s Growing Pharmaceutical Industry
Translating for the life science sector is one of the fastest growing translation areas worldwide. Due to the global emphasis translation quality…
CFDA：中国医药监管的未来与机会
中国食品药品监督管理局（CFDA）成立于2013年。原来称作“国家食品药品监督管理局”（State Food and Drug Administration，简称SFDA），后改名为“国家食品药品监督管理总局”（China Food and Drug Administration，简称CFDA），将多个监管机构合并为食品和药物安全的唯一监管机构。
Cross Cultural Writing Best Practices
When writing for a cross-cultural audience it is important to keep a few things in mind. While we all know that shorter, more simple sentences…